skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I currently have 1/2 positions in MSL,CPH and SVC. MSL and CPH look like dead money with not a lot of growth potential going forward. SVC looks okay. I'm looking to enter a full position with PHO using proceeds from the sale of MSL and CPH (I would keep SVC for now and monitor). For heath care representation in my portfolio, I have a full position in GUD already (thanks 5i)! For a growth oriented portfolio, will this be a good move 3-5 years out? What do you consider an attractive entry point for PHO?

Thanks!
Read Answer Asked by WAYNE on April 20, 2017
Q: I have listed the small/med/cap companies I have on my watch list and am seeking your advise as to which three companies you would recommend my investing in from this list. (or some other that I have not listed) Many of these companies you have recommended on BNN. I look forward to your answer.
Read Answer Asked by Bob on April 19, 2017
Q: Are you seeing any news to account for the sell off in this stock? I noticed volume was not extreme. This still on your radar as an future addition to the growth portfolio?
Read Answer Asked by Edgar on April 19, 2017
Q: We have done very well on this name, so it has become one of our top holdings from a very modest position. It just had its best 6 month on the chart. Are the fundamentals all there? I like the idea of their mobile phone offering : Ting. I think one of the big names might like to buy them to take them of their oligomarket, this is my reason for having kept so far. Your opinion is valued, always.
Read Answer Asked by francois on April 19, 2017
Q: Hi, So, another good little company gets swallowed up, what would you do know, sell now, and if so any suggestions as to what to buy to replace what was to be a long term hold, or just hold the cash until something juicy comes along, like freshi?
Read Answer Asked by Greg on April 18, 2017
Q: Hi, The recent large acquisition seems to have garnered strong market interest. After staying at $2.05-$2.15 level for a few days, stock price has taken off to new highs over last week, on heavy volume. Your recent comments indicate some concern over debt financing and have kept me on the sidelines. Am I missing the boat and is it worth starting with a partial position at these levels?
Read Answer Asked by rajeev on April 17, 2017
Q: Greetings, Peter, Ryan and Co.
I am trying to evaluate the upside potential of ImmunoPrecise Antibodies (IPA.V), a microcap in the very dangerous junior biotech sector. I would appreciate any insights/opinion that you might have, if any, and any sources you would recommend I use to do some more due diligence. My usual sources are of little value.
With appreciation.
Ed
Read Answer Asked by Ed on April 17, 2017
Q: Hi Peter,

I have had ESP for 2-3 years and I have seen it as high as $4 when a potential deal with Rogers was in the works. It is currently my largest holding. ESP's last quarter was very positive and gave the price a good bump which has since dwindled. With approximatley $1.15 per share in cash, can we assume 1.5 X cash = $1.72 as a minimum value for this company? This has been the valuation I am basing my decisions on. With the current price approaching $2 a share (my average), I see good potential with manageable risk.

I look forward to your opinion on this one.

Cheers,
Read Answer Asked by Ryan on April 13, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!